Regulation of cocaine-reinstated drug-seeking behavior by κ-opioid receptors in the ventral tegmental area of rats

被引:14
作者
Sun, WenLin [1 ]
Xue, YueQiang [1 ]
Huang, ZaiFang [1 ]
Steketee, Jeffery D. [1 ]
机构
[1] Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, Memphis, TN 38163 USA
关键词
Cocaine; Reinstatement; kappa-Opioid receptors; Dopamine; Ventral tegmental area; Prefrontal cortex; Amygdala; BASOLATERAL AMYGDALA; PREFRONTAL CORTEX; LIDOCAINE INACTIVATION; DOPAMINE NEURONS; SQUIRREL-MONKEYS; GLUTAMATE; REWARD; RELAPSE; STRESS; MECHANISMS;
D O I
10.1007/s00213-010-1812-0
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Relapse is one of the main challenges facing the current treatment of cocaine addiction. Understanding its neurobiological mechanism is a critical step toward developing effective anti-relapse therapies. Emerging evidence indicates that glutamate-mediated activation of dopamine (DA) neurons in the ventral tegmental area (VTA) may be critically involved in cocaine-induced relapse to drug-seeking behavior. Activity of VTA DA neurons is modulated by multiple neurotransmitter systems including opioids, serotonin, dopamine, and acetylcholine. Recent studies demonstrated that activation of kappa-opioid receptors (kappa ORs) in the rat VTA directly inhibits the activity of a subpopulation of DA neurons projecting to the prefrontal cortex (PFC) and amygdala. Because we previously showed that blockade of DA receptors in the dorsal PFC inhibits cocaine-induced reinstatement of extinguished cocaine-seeking behavior suggesting a critical role of the VTA-PFC DA circuit in this process, we tested the hypothesis that activation of kappa ORs in the VTA will block cocaine-induced reinstatement in rats. Rats were trained to self-administer intravenous cocaine (0.125 mg/infusion) under a modified fixed-ratio five schedule. After extinction of the learned behavior, the effects of activation of VTA kappa ORs on cocaine-induced reinstatement were studied. The kappa OR agonist U50 488 (0-5.6 mu g/side) microinjected into the VTA dose-dependently decreased cocaine-induced reinstatement. The effects could not be explained by either a disruption of operant behavior or diffusion of the drug to the areas surrounding the VTA. Moreover, the effect was reversed by norbinaltorphimine. The VTA DA neurons expressing functional kappa ORs are critically involved in cocaine-induced reinstatement in rats.
引用
收藏
页码:179 / 188
页数:10
相关论文
共 39 条
[1]   Effects of SCH-23390 infused into the amygdala or adjacent cortex and basal ganglia on cocaine seeking and self-administration in rats [J].
Alleweireldt, AT ;
Hobbs, RJ ;
Taylor, AR ;
Neisewander, JL .
NEUROPSYCHOPHARMACOLOGY, 2006, 31 (02) :363-374
[2]  
BALSKUBIK R, 1993, J PHARMACOL EXP THER, V264, P489
[3]   Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats [J].
Beardsley, PM ;
Howard, JL ;
Shelton, KL ;
Carroll, FI .
PSYCHOPHARMACOLOGY, 2005, 183 (01) :118-126
[4]   Activator of G protein signaling 3: A gatekeeper of cocaine sensitization and drug seeking [J].
Bowers, MS ;
McFarland, K ;
Lake, RW ;
Peterson, YK ;
Lapish, CC ;
Gregory, ML ;
Lanier, SM ;
Kalivas, PW .
NEURON, 2004, 42 (02) :269-281
[5]  
Caine SB, 1999, J PHARMACOL EXP THER, V291, P353
[6]   A role for the prefrontal cortex in stress- and cocaine-induced reinstatement of cocaine seeking in rats [J].
Capriles, N ;
Rodaros, D ;
Sorge, RE ;
Stewart, J .
PSYCHOPHARMACOLOGY, 2003, 168 (1-2) :66-74
[7]  
Carey GJ, 2001, J PHARMACOL EXP THER, V297, P215
[8]   Cocaine but not natural reward self-administration nor passive cocaine infusion produces persistent LTP in the VTA [J].
Chen, Billy T. ;
Bowers, M. Scott ;
Martin, Miquel ;
Hopf, F. Woodward ;
Guillory, Anitra M. ;
Carelli, Regina M. ;
Chou, Jonathan K. ;
Bonci, Antonello .
NEURON, 2008, 59 (02) :288-297
[9]   Dissociation of primary and secondary reward-relevant limbic nuclei in an animal model of relapse [J].
Grimm, JW ;
See, RE .
NEUROPSYCHOPHARMACOLOGY, 2000, 22 (05) :473-479
[10]  
JOHNSON SW, 1992, J NEUROSCI, V12, P483